Factors associated with antiretroviral therapy use among pregnant women in rural and urban settings in Southern Province, Zambia: 2016–2019
Objectives To assess antiretroviral therapy (ART) coverage among pregnant women living with HIV and compare the characteristics of women who received and did not receive ART during pregnancy in Zambia. Methods A cross‐sectional study was conducted at urban and rural health facilities in Southern Pro...
Gespeichert in:
Veröffentlicht in: | Tropical medicine & international health 2022-10, Vol.27 (10), p.902-912 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 912 |
---|---|
container_issue | 10 |
container_start_page | 902 |
container_title | Tropical medicine & international health |
container_volume | 27 |
creator | Morales, Juliet A. Hamahuwa, Mutinta Moyo, Nkumbula Mutanga, Jane N. Schue, Jessica L. Maunga, Sylvia Thuma, Philip E. Moss, William J. Sutcliffe, Catherine G. |
description | Objectives
To assess antiretroviral therapy (ART) coverage among pregnant women living with HIV and compare the characteristics of women who received and did not receive ART during pregnancy in Zambia.
Methods
A cross‐sectional study was conducted at urban and rural health facilities in Southern Province, Zambia, from 2016 to 2019. Pregnant women living with HIV delivering at study sites were enrolled and administered a questionnaire, and the results of infant diagnostic testing for HIV at birth was documented.
Results
About 1184 mother/infant pairs were enrolled. ART coverage was 93.7%. Most women who did not receive ART during pregnancy reported HIV diagnosis at delivery (18.0%) or during pregnancy (57.7%). The primary reported reason for not receiving ART was not wanting to take the drugs. Women who did not receive ART during pregnancy were significantly younger, less likely to have disclosed their HIV‐infection status to others, and less likely to have received antenatal care than women who received ART. ART use correlated with higher levels of education in urban but not rural sites. Overall, 1.0% of infants were infected with HIV at birth, including 0.8% of infants born to women who received ART and 4.1% of infants born to women who did not.
Conclusions
Most women received ART according to guidelines, resulting in low perinatal transmission rates of HIV to infants. Efforts to increase ART coverage and prevent vertical transmission should focus on identifying incident HIV infections during pregnancy and strengthening counselling for newly diagnosed pregnant women. |
doi_str_mv | 10.1111/tmi.13816 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2716524208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2720221342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-cae09f001725da4d3ea37450d71950a6956ce90439f2b7d7632f05fe6aa7ea83</originalsourceid><addsrcrecordid>eNp10ctO3DAUBmCrAhUKXfQFkKVuqETAl9iZsEOjcpGoitRZdROdSU4Go8Se2g6j2fUFuuob8iQ4DLBAwptjyZ9-Wecn5Atnxzydk9ibYy4nXH8gu1xqlUmu9NbTnWVCFHqHfArhjjGW50p_JDtSc1HwfLJL_p1DHZ0PFEJwtYGIDV2ZeEvBRuMxendvPHQ03qKH5ZoOASn0zi7o0uPCJkVXrkdLjaV-GCXYhg5-DpYGjNHYRRjffrlhjLD0Zky0NR7R39DPDZxSwbh--Ps_jXKfbLfQBfz8PPfI7Pz7bHqZXf-8uJqeXWe1VFJnNSArW8Z4IVQDeSMRZJEr1hS8VAx0qXSNJctl2Yp50RRaipapFjVAgTCRe-RwE7v07s-AIVa9CTV2HVh0Q6jSbrQSuWAj_fqG3rnB2_S5pAQTgstcJPVto2rvQvDYVktvevDrirNqrKhKFVVPFSV78Jw4zHtsXuVLJwmcbMDKdLh-P6ma_bjaRD4CbV-bsA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2720221342</pqid></control><display><type>article</type><title>Factors associated with antiretroviral therapy use among pregnant women in rural and urban settings in Southern Province, Zambia: 2016–2019</title><source>MEDLINE</source><source>Wiley Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Morales, Juliet A. ; Hamahuwa, Mutinta ; Moyo, Nkumbula ; Mutanga, Jane N. ; Schue, Jessica L. ; Maunga, Sylvia ; Thuma, Philip E. ; Moss, William J. ; Sutcliffe, Catherine G.</creator><creatorcontrib>Morales, Juliet A. ; Hamahuwa, Mutinta ; Moyo, Nkumbula ; Mutanga, Jane N. ; Schue, Jessica L. ; Maunga, Sylvia ; Thuma, Philip E. ; Moss, William J. ; Sutcliffe, Catherine G.</creatorcontrib><description>Objectives
To assess antiretroviral therapy (ART) coverage among pregnant women living with HIV and compare the characteristics of women who received and did not receive ART during pregnancy in Zambia.
Methods
A cross‐sectional study was conducted at urban and rural health facilities in Southern Province, Zambia, from 2016 to 2019. Pregnant women living with HIV delivering at study sites were enrolled and administered a questionnaire, and the results of infant diagnostic testing for HIV at birth was documented.
Results
About 1184 mother/infant pairs were enrolled. ART coverage was 93.7%. Most women who did not receive ART during pregnancy reported HIV diagnosis at delivery (18.0%) or during pregnancy (57.7%). The primary reported reason for not receiving ART was not wanting to take the drugs. Women who did not receive ART during pregnancy were significantly younger, less likely to have disclosed their HIV‐infection status to others, and less likely to have received antenatal care than women who received ART. ART use correlated with higher levels of education in urban but not rural sites. Overall, 1.0% of infants were infected with HIV at birth, including 0.8% of infants born to women who received ART and 4.1% of infants born to women who did not.
Conclusions
Most women received ART according to guidelines, resulting in low perinatal transmission rates of HIV to infants. Efforts to increase ART coverage and prevent vertical transmission should focus on identifying incident HIV infections during pregnancy and strengthening counselling for newly diagnosed pregnant women.</description><identifier>ISSN: 1360-2276</identifier><identifier>ISSN: 1365-3156</identifier><identifier>EISSN: 1365-3156</identifier><identifier>DOI: 10.1111/tmi.13816</identifier><identifier>PMID: 36127148</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Anti-HIV Agents - therapeutic use ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Birth ; Cross-Sectional Studies ; Disease transmission ; Drug therapy ; Female ; Health care facilities ; HIV ; HIV Infections - prevention & control ; Human immunodeficiency virus ; Humans ; Infant ; Infant, Newborn ; Infants ; Infections ; Infectious Disease Transmission, Vertical - prevention & control ; paediatrics ; Parturition ; Pregnancy ; Pregnancy Complications, Infectious - drug therapy ; Pregnant Women ; prevention of mother‐to‐child HIV transmission ; sub‐Saharan Africa ; Urban areas ; Urban environments ; Zambia - epidemiology</subject><ispartof>Tropical medicine & international health, 2022-10, Vol.27 (10), p.902-912</ispartof><rights>2022 John Wiley & Sons Ltd.</rights><rights>2022 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-cae09f001725da4d3ea37450d71950a6956ce90439f2b7d7632f05fe6aa7ea83</citedby><cites>FETCH-LOGICAL-c3536-cae09f001725da4d3ea37450d71950a6956ce90439f2b7d7632f05fe6aa7ea83</cites><orcidid>0000-0001-7231-0188</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ftmi.13816$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ftmi.13816$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36127148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morales, Juliet A.</creatorcontrib><creatorcontrib>Hamahuwa, Mutinta</creatorcontrib><creatorcontrib>Moyo, Nkumbula</creatorcontrib><creatorcontrib>Mutanga, Jane N.</creatorcontrib><creatorcontrib>Schue, Jessica L.</creatorcontrib><creatorcontrib>Maunga, Sylvia</creatorcontrib><creatorcontrib>Thuma, Philip E.</creatorcontrib><creatorcontrib>Moss, William J.</creatorcontrib><creatorcontrib>Sutcliffe, Catherine G.</creatorcontrib><title>Factors associated with antiretroviral therapy use among pregnant women in rural and urban settings in Southern Province, Zambia: 2016–2019</title><title>Tropical medicine & international health</title><addtitle>Trop Med Int Health</addtitle><description>Objectives
To assess antiretroviral therapy (ART) coverage among pregnant women living with HIV and compare the characteristics of women who received and did not receive ART during pregnancy in Zambia.
Methods
A cross‐sectional study was conducted at urban and rural health facilities in Southern Province, Zambia, from 2016 to 2019. Pregnant women living with HIV delivering at study sites were enrolled and administered a questionnaire, and the results of infant diagnostic testing for HIV at birth was documented.
Results
About 1184 mother/infant pairs were enrolled. ART coverage was 93.7%. Most women who did not receive ART during pregnancy reported HIV diagnosis at delivery (18.0%) or during pregnancy (57.7%). The primary reported reason for not receiving ART was not wanting to take the drugs. Women who did not receive ART during pregnancy were significantly younger, less likely to have disclosed their HIV‐infection status to others, and less likely to have received antenatal care than women who received ART. ART use correlated with higher levels of education in urban but not rural sites. Overall, 1.0% of infants were infected with HIV at birth, including 0.8% of infants born to women who received ART and 4.1% of infants born to women who did not.
Conclusions
Most women received ART according to guidelines, resulting in low perinatal transmission rates of HIV to infants. Efforts to increase ART coverage and prevent vertical transmission should focus on identifying incident HIV infections during pregnancy and strengthening counselling for newly diagnosed pregnant women.</description><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Birth</subject><subject>Cross-Sectional Studies</subject><subject>Disease transmission</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Health care facilities</subject><subject>HIV</subject><subject>HIV Infections - prevention & control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>Infections</subject><subject>Infectious Disease Transmission, Vertical - prevention & control</subject><subject>paediatrics</subject><subject>Parturition</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - drug therapy</subject><subject>Pregnant Women</subject><subject>prevention of mother‐to‐child HIV transmission</subject><subject>sub‐Saharan Africa</subject><subject>Urban areas</subject><subject>Urban environments</subject><subject>Zambia - epidemiology</subject><issn>1360-2276</issn><issn>1365-3156</issn><issn>1365-3156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10ctO3DAUBmCrAhUKXfQFkKVuqETAl9iZsEOjcpGoitRZdROdSU4Go8Se2g6j2fUFuuob8iQ4DLBAwptjyZ9-Wecn5Atnxzydk9ibYy4nXH8gu1xqlUmu9NbTnWVCFHqHfArhjjGW50p_JDtSc1HwfLJL_p1DHZ0PFEJwtYGIDV2ZeEvBRuMxendvPHQ03qKH5ZoOASn0zi7o0uPCJkVXrkdLjaV-GCXYhg5-DpYGjNHYRRjffrlhjLD0Zky0NR7R39DPDZxSwbh--Ps_jXKfbLfQBfz8PPfI7Pz7bHqZXf-8uJqeXWe1VFJnNSArW8Z4IVQDeSMRZJEr1hS8VAx0qXSNJctl2Yp50RRaipapFjVAgTCRe-RwE7v07s-AIVa9CTV2HVh0Q6jSbrQSuWAj_fqG3rnB2_S5pAQTgstcJPVto2rvQvDYVktvevDrirNqrKhKFVVPFSV78Jw4zHtsXuVLJwmcbMDKdLh-P6ma_bjaRD4CbV-bsA</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Morales, Juliet A.</creator><creator>Hamahuwa, Mutinta</creator><creator>Moyo, Nkumbula</creator><creator>Mutanga, Jane N.</creator><creator>Schue, Jessica L.</creator><creator>Maunga, Sylvia</creator><creator>Thuma, Philip E.</creator><creator>Moss, William J.</creator><creator>Sutcliffe, Catherine G.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7231-0188</orcidid></search><sort><creationdate>202210</creationdate><title>Factors associated with antiretroviral therapy use among pregnant women in rural and urban settings in Southern Province, Zambia: 2016–2019</title><author>Morales, Juliet A. ; Hamahuwa, Mutinta ; Moyo, Nkumbula ; Mutanga, Jane N. ; Schue, Jessica L. ; Maunga, Sylvia ; Thuma, Philip E. ; Moss, William J. ; Sutcliffe, Catherine G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-cae09f001725da4d3ea37450d71950a6956ce90439f2b7d7632f05fe6aa7ea83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Birth</topic><topic>Cross-Sectional Studies</topic><topic>Disease transmission</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Health care facilities</topic><topic>HIV</topic><topic>HIV Infections - prevention & control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>Infections</topic><topic>Infectious Disease Transmission, Vertical - prevention & control</topic><topic>paediatrics</topic><topic>Parturition</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - drug therapy</topic><topic>Pregnant Women</topic><topic>prevention of mother‐to‐child HIV transmission</topic><topic>sub‐Saharan Africa</topic><topic>Urban areas</topic><topic>Urban environments</topic><topic>Zambia - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morales, Juliet A.</creatorcontrib><creatorcontrib>Hamahuwa, Mutinta</creatorcontrib><creatorcontrib>Moyo, Nkumbula</creatorcontrib><creatorcontrib>Mutanga, Jane N.</creatorcontrib><creatorcontrib>Schue, Jessica L.</creatorcontrib><creatorcontrib>Maunga, Sylvia</creatorcontrib><creatorcontrib>Thuma, Philip E.</creatorcontrib><creatorcontrib>Moss, William J.</creatorcontrib><creatorcontrib>Sutcliffe, Catherine G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Tropical medicine & international health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morales, Juliet A.</au><au>Hamahuwa, Mutinta</au><au>Moyo, Nkumbula</au><au>Mutanga, Jane N.</au><au>Schue, Jessica L.</au><au>Maunga, Sylvia</au><au>Thuma, Philip E.</au><au>Moss, William J.</au><au>Sutcliffe, Catherine G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with antiretroviral therapy use among pregnant women in rural and urban settings in Southern Province, Zambia: 2016–2019</atitle><jtitle>Tropical medicine & international health</jtitle><addtitle>Trop Med Int Health</addtitle><date>2022-10</date><risdate>2022</risdate><volume>27</volume><issue>10</issue><spage>902</spage><epage>912</epage><pages>902-912</pages><issn>1360-2276</issn><issn>1365-3156</issn><eissn>1365-3156</eissn><abstract>Objectives
To assess antiretroviral therapy (ART) coverage among pregnant women living with HIV and compare the characteristics of women who received and did not receive ART during pregnancy in Zambia.
Methods
A cross‐sectional study was conducted at urban and rural health facilities in Southern Province, Zambia, from 2016 to 2019. Pregnant women living with HIV delivering at study sites were enrolled and administered a questionnaire, and the results of infant diagnostic testing for HIV at birth was documented.
Results
About 1184 mother/infant pairs were enrolled. ART coverage was 93.7%. Most women who did not receive ART during pregnancy reported HIV diagnosis at delivery (18.0%) or during pregnancy (57.7%). The primary reported reason for not receiving ART was not wanting to take the drugs. Women who did not receive ART during pregnancy were significantly younger, less likely to have disclosed their HIV‐infection status to others, and less likely to have received antenatal care than women who received ART. ART use correlated with higher levels of education in urban but not rural sites. Overall, 1.0% of infants were infected with HIV at birth, including 0.8% of infants born to women who received ART and 4.1% of infants born to women who did not.
Conclusions
Most women received ART according to guidelines, resulting in low perinatal transmission rates of HIV to infants. Efforts to increase ART coverage and prevent vertical transmission should focus on identifying incident HIV infections during pregnancy and strengthening counselling for newly diagnosed pregnant women.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>36127148</pmid><doi>10.1111/tmi.13816</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7231-0188</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1360-2276 |
ispartof | Tropical medicine & international health, 2022-10, Vol.27 (10), p.902-912 |
issn | 1360-2276 1365-3156 1365-3156 |
language | eng |
recordid | cdi_proquest_miscellaneous_2716524208 |
source | MEDLINE; Wiley Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content |
subjects | Anti-HIV Agents - therapeutic use Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Birth Cross-Sectional Studies Disease transmission Drug therapy Female Health care facilities HIV HIV Infections - prevention & control Human immunodeficiency virus Humans Infant Infant, Newborn Infants Infections Infectious Disease Transmission, Vertical - prevention & control paediatrics Parturition Pregnancy Pregnancy Complications, Infectious - drug therapy Pregnant Women prevention of mother‐to‐child HIV transmission sub‐Saharan Africa Urban areas Urban environments Zambia - epidemiology |
title | Factors associated with antiretroviral therapy use among pregnant women in rural and urban settings in Southern Province, Zambia: 2016–2019 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A48%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20antiretroviral%20therapy%20use%20among%20pregnant%20women%20in%20rural%20and%20urban%20settings%20in%20Southern%20Province,%20Zambia:%202016%E2%80%932019&rft.jtitle=Tropical%20medicine%20&%20international%20health&rft.au=Morales,%20Juliet%20A.&rft.date=2022-10&rft.volume=27&rft.issue=10&rft.spage=902&rft.epage=912&rft.pages=902-912&rft.issn=1360-2276&rft.eissn=1365-3156&rft_id=info:doi/10.1111/tmi.13816&rft_dat=%3Cproquest_cross%3E2720221342%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2720221342&rft_id=info:pmid/36127148&rfr_iscdi=true |